期刊文献+

肺炎克雷伯菌临床分离株aae(6′)-Ib-cr基因的检测 被引量:4

Prevalence of aac(6′)-Ib.cr in clinical isolates of Klebsiella pneumoniae
原文传递
导出
摘要 目的调查肺炎克雷伯菌临床分离株aac(6′)-Ib—cr基因存在情况。方法收集2006年1月至2007年9月从临床分离的337株非重复的肺炎克雷伯菌。挑选64株对庆大霉素、阿米卡星和妥布霉素任何一种耐药的肺炎克雷伯菌临床分离株进行aac(6′)-Ib-cr基因检测,采用PCR法检测aac(6′)-Ib和Ⅰ类整合酶基因(intll),通过DNA直接测序确定aac(6′)-Ib-cr。抗生素MIC值测定采用琼脂稀释法。ESBLs检测采用双纸片扩散法,通过接合试验检测质粒是否可以发生转移。结果337株肺炎克雷伯菌临床分离株中,对庆大霉素、阿米卡星和妥布霉素的耐药率分别为19.0%(64/337)、8,3%(28/337)和16.3%(55/337)。共有24株细菌经PCR证实aac(6′)-Ib基因阳性,经测序证实全部为aac(6′)-Ib-cr基因,阳性率为37.5%(24/64)。24株aac(6′)-Ib-cr基因阳性株中,有13株对环丙沙星耐药(MIC≥2mg/L)和11株环丙沙星敏感(MIC≤0.25—1.0mg/L)。aac(6′)-Ib-cr基因在环丙沙星耐药菌株和环丙沙星敏感菌株中的检出率分别为54.2%(13/24)和27.5%(11/40),经χ^2检验,差异具有统计学意义(χ^2=11,056,P〈0.01)。24株aac(6′)-Ib-cr基因阳性株中,ESBLs和intll基因的阳性率分别为79.2%(19/24)和91.7%(22/24)。13株aac(6′)-Ib—cr基因阳性菌株的质粒成功转移至受体菌,以受体菌质粒DNA为模板进行aac(6′)-Ib-cr检测,13株受体菌质粒全部为aac(6′)-Ib-cr基因和intl基因阳性,全部为ESBLs阳性株。结论aac(6′)-Ib-cr基因广泛存在于肺炎克雷伯菌临床分离株中,aac(6′)-Ib-cr可能通过Ⅰ类整合子和ESBL基因同时位于可转移的质粒上造成传播。 Objective To investigate the prevalence of aac (6′)-Ib-cr in clinical isolates of Klebsiella pneumoniae. Methods A total of 337 isolates of Klebsiella pneumoniae were isolated from clinical specimens in our hospital from Jan,2006 to Sep, 2007. Gentamycin, amikacin or tobramicin was used to screen the isolated with aac(6′)-Ib-cr, aac(6′)-Ib and class 1 interase gene( intll ) was determined by PCR. All PCR products of aac (6′)-Ib were sequenced for determination of aac (6′)-Ib-cr. MICs of antibiotics were determined by agar dilution method. The ESBLs-producing isolates were determined by the CISI-recommended confirmatory tests. Conjugation test was used to detect the transfer of plasmid. Results Of the 337 clinical isolates of Klebsiella pneumoniae, 64 ( 19. 0% ) , 28 (8.3 % ) and 55 ( 16.3 % ) isolates were resistant to gentamycin, amikacin and tobramycin, respectively. Among 64 gentamycin-resistant isolates, 24 (37.5%) were positive for aac (6′)-Ib-cr, including 13 ciprofloxacin-resistant isolates and 11 ciprofloxacin- susceptible isolates. The prevalence of aac (6′)-Ib-cr in ciprofloxacin-resistant and -susceptible isolates were 54.2 % ( 13/24 ) and 27.5% (11/40). The positive rates of ESBLs and intll in the 24 isolates carrying aac (6′)-Ib-cr were 79.2% (19/24)and 91.7% (22/24). Plasmids carrying aac(6′)-Ib-cr of 13 isolates were successfully transferred to E. coli J53. Plasmids of all transconjugants were positive for aac (6′)-Ib-cr and intll. All transconjugants were ESBL producing strains. Conclusions aac (6′)-Ib-cr exists widely in clinical isolates of Klebsiella pneumoniae, aac (6′)-Ib-cr and ESBL gene usually coexist in a self- transmissible conjugative plasmid by class 1 integron.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2008年第9期975-978,共4页 Chinese Journal of Laboratory Medicine
关键词 克雷伯菌 肺炎 乙酰基转移酶类 Β内酰胺酶类 整合子类 Klebsiella pneumoniae Acetyhransferases beta-Lactamases Integrons
  • 相关文献

参考文献7

  • 1Robicsek A, Strahilevitz J, Jacoby GA, et al. Fluoroquinolonemodifying enzyme:a new adaptation of a common aminoglycoside acetyltransferase. Nat Med, 2006, 12:83-88.
  • 2Park CH, Robicsek A, Jacoby GA, et al. Prevalence in the United States of aac (6')-Ib-cr encoding a ciprofloxacinmodifying enzyme. Antimicrob Agents Chemother, 2006, 50:3953-3955.
  • 3Clinical and Laboratory Standards Institute. M100-S17 Performance standards for antimicrobial susceptibility testing, 17th informational supplement . 2006 .
  • 4吕霞,李从荣.质粒介导的喹诺酮耐药qnr基因的检测[J].中国感染与化疗杂志,2007,7(1):58-60. 被引量:10
  • 5Ambrozic Avgustin J, Keber R, Zerjavic K, et al. Emergence of the quinolone resistance-mediating gene aac (6')-Ib-cr in extended-spectrum-beta-lactamase-producing Klebsiella isolates collected in Slovenia between 2000 and 2005. Antimicrob Agents Chemother, 2007,51 : 4171- 4173.
  • 6Quiroga MP, Andres P, Petroni A, et al. Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical Enterobacterial isolates from argentina. Antimicrob Agents Chemother, 2007,51: 4466-4470.
  • 7Xu X, Wu S, Ye X, et al. Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1. Antimicrob Agents Chemother, 2007, 51:4105-4110.

二级参考文献6

  • 1李涛,熊自忠,沈继录,周强,徐元宏,王中新.大肠埃希菌与克雷伯菌属细菌qnr基因的检测[J].检验医学,2005,20(2):112-114. 被引量:35
  • 2王春新,蔡培泉,黄支密,糜祖煌,秦玲,过毅.阴沟肠杆菌喹诺酮类耐药qnr基因的发现[J].中华微生物学和免疫学杂志,2006,26(2):162-162. 被引量:28
  • 3Wang M,Tran JH,Jacoby GA,et al.Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai,China[J].Antimicrob Agents Chemother,2003,47(7):2242-2248.
  • 4Chanal C,Sirot D,Romaszko JP,et al.Survey of extendedspectrum β-lactamases among Enterobacteriaceae[J].J Antimicrob Chemother,1996,38(1):127-132.
  • 5Martinez-Martinez L,Pascual A,Jacoby GA.Quinolone resistance from a transferable plasmid[J].Lancet,1998,351(9105):797-799.
  • 6National Committee for Clinical Laboratory Standard.Performanee standards for antimicrohial susceptiblity testing[S].Fourteenth informational supplement M100-S14.NCCLS,2004,24:30-35.

共引文献9

同被引文献40

  • 1王春新,蔡培泉,黄支密,糜祖煌,秦玲,过毅.阴沟肠杆菌喹诺酮类耐药qnr基因的发现[J].中华微生物学和免疫学杂志,2006,26(2):162-162. 被引量:28
  • 2陆坚,吴伟元,吴创鸿,文丽霞,单万水,张国良,李丽雄.革兰阴性菌qnrA基因介导的喹诺酮耐药分子机制研究[J].中华微生物学和免疫学杂志,2007,27(4):373-378. 被引量:8
  • 3潘韵峰,周华,俞云松.导致高水平氨基糖苷类抗生素耐药的新型16SrRNA甲基化酶研究进展[J].中华检验医学杂志,2007,30(6):699-701. 被引量:28
  • 4Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones [J]. Clin Infect D/s,2000,31 (suppl 2):24-28.
  • 5Martinez-Martinez L, Paseual A, Jacoby GA. Quinolone resistance from a transferable plasmid [J]. Lancet,1998,351:797-799.
  • 6Hata M,Suzuki M,Matsumoto M ,et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b [J ]. Antimicrob Agents Chemother, 2005,49(2) : 801-803.
  • 7Jacoby GA ,Walsh KE,Mills DM ,et al. QnrB,another plasmid-mediated gene for quinolone resistance [J]. Antimicrob Agents Chemother, 2006, 50 (4):1178-1182.
  • 8Robicsek A,Strahilevitz J, Jacoby GA,et al. Fluoroquinolone modifying enzyme:a new adaptation of a common aminoglycoside aeetyltransferase [J]. Nat Med, 2006,12 : 83-88.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. CLSI M100-S17 [S]. Clinical and Laboratory Standards Institute, Wayne ,PA. 2007.
  • 10Park CH,Robicsek A,Jacoby GA,et al. Prevalellee in the United States of aac (6 ')-Ib-cr encoding a ciprofloxacin-modifying enzyme [J]. A.ntimicrob Agents Chemother, 2006,59(11) : 3953-3955.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部